Abstract
The incidence of breast cancer among Japanese women is substantially increasing. This population-based prospective cohort study in Japan evaluated the associations of reproductive factors and exogenous female hormone use with breast cancer risk, both overall and separately among premenopausal and postmenopausal women. A total of 24,064 women aged 40–64 were followed from 1990 to 2003. During 309,424 person-years of follow-up, 285 breast cancer cases were documented. In overall evaluation, nulliparity was significantly associated with an increased risk of breast cancer. There was a significant decrease in risk with increasing parity number among parous women (trend P = 0.008). No association was observed between age at menarche or age at first birth and breast cancer risk. Neither oral contraceptive (OC) use nor the use of exogenous female hormones other than OC was associated with breast cancer risk. The evaluation according to menopausal status revealed that nulliparity and parity number were significantly related to breast cancer risk only among postmenopausal women. Later age at natural menopause was associated with an increased risk of breast cancer among postmenopausal women (trend P = 0.02). Our findings suggest that parity number and age at menopause have great effects on breast cancer risk among Japanese women.
Similar content being viewed by others
Abbreviations
- OC:
-
Oral contraceptive
- HRT:
-
Hormone replacement therapy
- HR:
-
Hazard ratio
- CI:
-
Confidence interval
References
Curado MP, Edwards B, Shin HR et al (eds) (2007) Cancer Incidence in Five Continents, vol IX. IARC Scientific Publications No. 160, Lyon
Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T (2008) Cancer incidence and incidence rates in Japan in 2002: based on data from 11 population-based cancer registries. Jpn J Clin Oncol 38:641–648
Minami Y, Tsubono Y, Nishino Y, Ohuchi N, Shibuya D, Hisamichi S (2004) The increase of female breast cancer incidence in Japan: emergence of birth cohort effect. Int J Cancer 108:901–906
MacMahon B, Cole P, Lin TM et al (1970) Age at first birth and breast cancer risk. Bull World Health Organ 43:209–221
Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev 15:36–47
Lambe M, Hsieh CC, Trichopoulos D, Ekbom A, Pavia M, Adami HO (1994) Transient increase in the risk of breast cancer after giving birth. N Engl J Med 331:5–9
Chie WC, Hsieh CC, Newcomb PA et al (2000) Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol 151:715–722
Nagata C, Hu YH, Shimizu H (1995) Effects of menstrual and reproductive factors on the risk of breast cancer: meta-analysis of the case–control studies in Japan. Jpn J Cancer Res 86:910–915
Statistics and Information Department, Minister’s Secretariat, Ministry of Health, Labour and Welfare (2006) Live births: special report of vital statistics in fy 2005. Health and Welfare Statistics Association, Tokyo (in Japanese)
Statistics and Information Department, Minister’s Secretariat, Ministry of Health, Labour and Welfare (2007) Marriage statistics: special report of vital statistics in fy 2006. Health and Welfare Statistics Association, Tokyo (in Japanese)
Ministry of Health, Labour, Welfare (2006) The national health and nutrition survey in Japan, 2003. Daiichi-Shuppan, Tokyo (in Japanese)
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2007) Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. IARC Monogr Eval Carcinog Risks Hum vol 91, Lyon
Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 347:1713–1727
Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52, 705 women with breast cancer and 108, 411 women without breast cancer. Lancet 350:1047–1059
Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333
Hirose K, Tajima K, Hamajima N et al (1995) A large -scale hospital-based case–control study of risk factors of breast cancer according to menopausal status. Jpn J Cancer Res 86:146–154
Minami Y, Ohuchi N, Fukao A, Hisamichi S (1997) Risk factors for breast cancer: a case–control study of screen-detected breast cancer in Miyagi Prefecture, Japan. Breast Cancer Res Treat 44:225–233
Clavel-Chapelon F, the E3 N-EPIC Group (2002) Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women. Br J Cancer 86:723–727
Iwasaki M, Otani T, Inoue M, Sasazuki S, Tsugane S (2007) Role and impact of menstrual and reproductive factors on breast cancer risk in Japan. Eur J Cancer Prev 16:116–123
Fukao A, Tsubono Y, Komatsu S et al (1995) A cohort study on the relation of lifestyle, personality and biologic markers to cancer in Miyagi, Japan: study design, response rate and profiles of the cohort subjects. J Epidemiol 5:153–157
Naganuma T, Kuriyama S, Kakizaki M et al (2008) Coffee consumption and the risk of oral, pharyngeal, and esophageal cancers in Japan: the Miyagi Cohort Study. Am J Epidemiol 168:1425–1432
Doll R, Payne P, Waterhouse JAH (1966) Cancer incidence in five continents: a technical report. Vol 3: IARC scientific publications. International Union against Cancer, Genève, pp 118–123
Cox DR (1972) Regression models and life-tables (with discussion). J Roy Statist Soc 34:187–220
Gao YT, Shu XO, Dai Q et al (2000) Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer 87:295–300
Pharoah PDP, Day NE, Duffy S, Easton DF, Ponder BAJ (1997) Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 71:800–809
Tamakoshi K, Yatsuya H, Wakai K et al (2005) Impact of menstrual and reproductive factors on breast cancer risk in Japan: results of the JACC study. Cancer Sci 96:57–62
Health and Welfare Department Miyagi Prefecture (1993) Miyagi Prefecture. Report on special investigation for cancer prevention. Miyagi Cancer Society, Sendai (in Japanese)
Adami HO, Bergström R, Lund E, Meirik O (1990) Absence of association between reproductive variables and the risk of breast cancer in young women in Sweden and Norway. Br J Cancer 62:122–126
Pathak DR, Speizer FE, Willett WC, Rosner B, Lipnick RJ (1986) Parity and breast cancer risk: possible effect on age at diagnosis. Int J Cancer 37:21–25
Rosner B, Colditz GA, Willett WC (1994) Reproductive risk factors in a prospective study of breast cancer: the Nurses’ Health Study. Am J Epidemiol 139:819–835
Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease. Lancet 358:1389–1399
Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG (1983) ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer. Nature 303:767–770
Antoniou AC, Easton DF (2006) Models of genetic susceptibility to breast cancer. Oncogene 25:5898–5905
Bernstein L, Ross RK (1993) Endogenous hormones and breast cancer risk. Epidemiol Rev 15:48–65
Chubak J, Tworoger SS, Yasui Y, Ulrich CM, Stanczyk FZ, McTiernan A (2004) Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations. Cancer Epidemiol Biomarkers Prev 13:1296–1301
Hankinson SE, Colditz GA, Hunter DJ et al (1995) Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the nurses’ health study (United States). Cancer Causes Control 6:217–224
Dorgan JF, Reichman ME, Judd JT et al (1995) Relationships of age and reproductive characteristics with plasma estrogens and androgens in premenopausal women. Cancer Epidemiol Biomarkers Prev 4:381–386
Eliassen AH, Tworoger SS, Hankinson SE (2007) Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women. Int J Cancer 120:1536–1541
Goodman MT, Cologne JB, Moriwaki H, Vaeth M, Mabuchi K (1997) Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors. Prev Med 26:144–153
Nagata C, Matsushita Y, Inaba S, Kawakami N, Shimizu H (1997) Unapproved use of high-dose combined pills in Japan: a community study on prevalence and health characteristics of the users. Prev Med 26:565–569
Romieu I, Willett WC, Colditz GA et al (1989) Prospective study of oral contraceptive use and risk of breast cancer in women. J Natl Cancer Inst 81:1313–1321
Kahlenborn C, Modugno F, Potter DM, Severs WB (2006) Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis. Mayo Clin Proc 81:1290–1302
Shantakumar S, Terry MB, Paykin A et al (2007) Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk. Am J Epidemiol 165:1187–1198
Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD (2002) Postmenopausal hormone replacement therapy: scientific review. JAMA 288:872–881
Acknowledgments
This work was supported by a grant for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (grant number: H20-Kiban C-20590630) and in part by the 3rd Term Comprehensive Control Research for Cancer (grant number: H18-Senryaku-001) from the Ministry of Health, Labour and Welfare of Japan. None of the authors declare any personal or financial conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kawai, M., Minami, Y., Kuriyama, S. et al. Reproductive factors, exogenous female hormone use and breast cancer risk in Japanese: the Miyagi Cohort Study. Cancer Causes Control 21, 135–145 (2010). https://doi.org/10.1007/s10552-009-9443-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-009-9443-7